Welcome to This Week in Recovery, a weekly recap of the 5 biggest stories and developments in the recovery industry.
Construction Industry Aims To Help Workers Battling Addiction – Boston Globe
As numbers of construction workers who are dealing with substance abuse, business leaders are launching initiatives to help with those struggling with these issues. Employers organizing these events and initiatives will look to treat substance abuse like other diseases such as cancer and diabetes.
New Movement Aims to Deregulate Buprenorphine Prescriptions – STAT News
Eighteen state public health directors, physicians, and members of Congress are pushing to deregulate use of buprenorphine nationwide. The medication is highly regulated due to fears that opioid-based treatment drugs like buprenorphine and methadone could be misused. However, proponents point to France’s approach in the mid-1990s, when buprenorphine was first approved for use there. With no limits on who could prescribe the drug, overdose deaths fell by nearly 80% between 1994 and 2002.
Most Americans Want Drug Companies Held Accountable For Opioid Crisis – Vox
A new poll done by Ipsos on behalf of NPR, found that a majority of people, 56 percent, believe that companies should be held responsible for making opioid abuse worse. Other takeaways include over 70 percent of respondents believe that naloxone is effective and should be more widely available.
60 Minutes Confronts Fentanyl Distributors in China – 60 Minutes
60 Minutes conducted an “ambush interview” with a man accused of making deadly fentanyl in Shanghai. The confrontation was captured on hidden cameras and included in the story “Online Overdose,” about a Chinese drug lab. China has been criticized by the U.S. government for failing to put the many forms of fentanyl on its list of controlled drugs. Now, in a concession, China says, next month, all derivatives of fentanyl will be on its list. But U.S. law enforcement remains skeptical about whether China will crack down.
Investor Donates $9M to Harvard, MIT for Marijuana Research – Fox News
A cannabis investor, Charles R. Broderick is giving Harvard and MIT $9 million to study the health effects of marijuana. Both academic institutions said the donation was the largest private funding of marijuana research. One of the objectives of the research will be to determine the cognitive and psychological effects of marijuana.
Want more recovery reads? Check out our blog today!
Where Presidential Candidates Stand on the Opioid Crisis
One of the biggest subjects of concern today is the opioid crisis that has fueled the rise in drug overdose deaths over the past decade. Learn where each democratic candidate and the current incumbent stand when it comes to the opioid crisis so you know who to vote for when you fill out your ballot in 2020.
Choose Recovery Over Addiction
We're here 24/7 to help you get the care you need to live life on your terms, without drugs or alcohol. Talk to our recovery specialists today and learn about our integrated treatment programs.
